Doctors raise concerns over Sunshine Act

06/20/2013 | Modern Physician (free registration)

The CMS' Physician Payment Sunshine Act will make doctors and teaching hospitals' transactions with drug companies and medical technology manufacturers public starting Aug. 1, but some physicians voiced concerns, pointing out that over-interpreting such connections could be detrimental. Advocates of the Sunshine Act say the provision will help prevent conflicts of interest. While the burden of reporting transactions will fall mostly on drug companies and manufacturers, CMS notes it will benefit physicians to keep a record of all transactions with the companies.

View Full Article in:

Modern Physician (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA